LAKE · Lakeland Industries Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '26 | Q2 '25 | Q1 '25 | Q3 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $47.59M | $52.50M | $36.31M | $45.76M | $28.70M | $31.68M | $33.07M | $27.28M | - |
| Cost of Revenue | - | $33.45M | $33.68M | $20.13M | $27.20M | $16.26M | $18.32M | $18.89M | $16.22M | - |
| Gross Profit | - | $14.13M | $18.82M | $16.18M | $18.56M | $12.44M | $13.36M | $14.18M | $11.06M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | $20.09M | $19.28M | $13.98M | $17.75M | $10.51M | $9.74M | $10.45M | $9.61M | - |
| D&A | - | - | - | $647.0K | - | $533.0K | - | - | $425.0K | - |
| Operating Income | - | ($1.62M) | ($4.04M) | $2.20M | $807.0K | $1.94M | $3.62M | $3.73M | $1.45M | - |
| Interest Expense | - | $502.0K | $445.0K | $172.0K | $490.0K | $8.0K | $13.0K | $1.0K | $9.0K | - |
| Income Tax | - | $13.67M | ($5.21M) | $388.0K | $147.0K | $541.0K | $937.0K | $1.20M | $285.0K | - |
| Net Income | - | ($15.96M) | $766.0K | $1.65M | $86.0K | $1.32M | $2.62M | $2.46M | $1.13M | - |
| EPS - Basic | - | $0.01 | ($0.19) | $0.22 | - | $0.18 | $0.35 | $0.33 | $0.15 | - |
| EPS - Diluted | - | ($1.64) | ($0.19) | $0.22 | - | $0.18 | $0.34 | $0.32 | $0.14 | - |
Balance Sheet
| Line item | Q1 '26 | Q3 '26 | Q2 '25 | Q1 '25 | Q3 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.52M | $17.19M | $17.75M | $18.62M | $15.84M | $25.22M | $26.43M | $41.21M | $24.64M | $10.50M |
| Accounts Receivable | $32.04M | $30.28M | $30.93M | $27.63M | $26.56M | $19.17M | $18.23M | $17.68M | $17.30M | - |
| Inventory | $82.54M | $87.89M | $90.20M | $85.82M | $72.72M | $51.25M | $54.35M | $57.37M | $58.18M | - |
| Accounts Payable | $15.56M | $14.53M | $18.12M | $14.65M | $16.71M | $7.38M | $6.80M | $8.38M | $6.56M | - |
| Current Assets | $134.19M | $143.32M | $147.06M | $140.71M | $125.30M | $101.50M | $104.02M | $106.33M | $104.98M | - |
| Total Assets | $209.93M | $220.72M | $226.30M | $218.13M | $201.21M | $153.75M | $148.31M | $147.44M | $142.33M | - |
| Current Liabilities | $37.96M | $37.45M | $40.22M | $36.27M | $29.64M | $18.35M | $15.51M | $18.64M | $17.99M | - |
| Long-term Debt | $30.38M | - | $2.90M | $16.43M | - | - | - | - | - | - |
| Total Liabilities | $80.81M | $86.23M | $79.04M | $74.75M | $76.53M | $30.29M | $24.73M | $26.05M | $22.34M | - |
| Stockholders' Equity | $129.13M | $134.48M | $147.26M | $143.38M | $124.69M | $123.45M | $123.59M | $121.39M | $119.99M | - |
| Retained Earnings | $23.86M | $30.36M | $46.60M | $46.12M | $68.98M | $69.28M | $70.48M | $68.08M | $64.77M | - |
Cash Flow
| Line item | Q1 '26 | Q3 '26 | Q2 '25 | Q1 '25 | Q3 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | $293.0K | - | $3.67M | - | - | $1.91M | - |
| Investing Cash Flow | - | - | - | ($9.25M) | - | ($690.0K) | - | - | ($2.36M) | - |
| Financing Cash Flow | - | - | - | $11.59M | - | ($1.15M) | - | - | ($1.08M) | - |
| CapEx | - | - | - | $466.0K | - | $690.0K | - | - | $465.0K | - |
| Free Cash Flow | - | - | - | ($173.0K) | - | $2.98M | - | - | $1.45M | - |
Ratios
| Metric | Q1 '26 | Q3 '26 | Q2 '25 | Q1 '25 | Q3 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 29.7% | 35.8% | 44.6% | 40.6% | 43.4% | 42.2% | 42.9% | 40.5% | - |
| Operating margin | - | -3.4% | -7.7% | 6.1% | 1.8% | 6.8% | 11.4% | 11.3% | 5.3% | - |
| EBITDA margin | - | - | - | 7.8% | - | 8.6% | - | - | 6.9% | - |
| Net margin | - | -33.5% | 1.5% | 4.6% | 0.2% | 4.6% | 8.3% | 7.5% | 4.1% | - |
| Free cash flow margin | - | - | - | -0.5% | - | 10.4% | - | - | 5.3% | - |
| FCF / Net income | - | - | - | -0.10 | - | 2.26 | - | - | 1.28 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | 19.0% | 63.1% | 29.1% | 26.4% | 32.7% | 20.2% | - |
| Return on assets | - | -7.2% | 0.3% | 0.8% | 0.0% | 0.9% | 1.8% | 1.7% | 0.8% | - |
| Return on equity | - | -11.9% | 0.5% | 1.2% | 0.1% | 1.1% | 2.1% | 2.0% | 0.9% | - |
| Return on invested capital | - | - | -2.1% | 1.1% | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 3.53 | 3.83 | 3.66 | 3.88 | 4.23 | 5.53 | 6.71 | 5.70 | 5.84 | - |
| Quick ratio | 1.36 | 1.48 | 1.41 | 1.51 | 1.77 | 2.74 | 3.20 | 2.63 | 2.60 | - |
| Cash ratio | 0.33 | 0.46 | 0.44 | 0.51 | 0.53 | 1.37 | 1.70 | 2.21 | 1.37 | - |
| Leverage | ||||||||||
| Debt / Equity | 0.24 | - | 0.02 | 0.11 | - | - | - | - | - | - |
| Debt / Assets | 0.14 | - | 0.01 | 0.08 | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | 5.77 | - | - | - | - | - | - |
| Interest coverage | - | -3.2x | -9.1x | 12.8x | 1.6x | 242.3x | 278.5x | 3730.0x | 161.0x | - |
| Equity multiplier | 1.63 | 1.64 | 1.54 | 1.52 | 1.61 | 1.25 | 1.20 | 1.21 | 1.19 | - |
| Liabilities / Assets | 0.38 | 0.39 | 0.35 | 0.34 | 0.38 | 0.20 | 0.17 | 0.18 | 0.16 | - |
| Efficiency | ||||||||||
| Asset turnover | - | 0.22 | 0.23 | 0.17 | 0.23 | 0.19 | 0.21 | 0.22 | 0.19 | - |
| Inventory turnover | - | 0.38 | 0.37 | 0.23 | 0.37 | 0.32 | 0.34 | 0.33 | 0.28 | - |
| Days sales outstanding | - | 232d | 215d | 278d | 212d | 244d | 210d | 195d | 231d | - |
| Days inventory outstanding | - | 959d | 978d | 1557d | 976d | 1151d | 1083d | 1109d | 1309d | - |
| Days payable outstanding | - | 159d | 196d | 266d | 224d | 166d | 136d | 162d | 148d | - |
| Cash conversion cycle | - | 1033d | 996d | 1569d | 963d | 1229d | 1157d | 1142d | 1393d | - |
| Valuation | ||||||||||
| P / E | - | - | - | 74.2x | - | 100.1x | 43.0x | 48.3x | 103.4x | - |
| P / B | - | 1.2x | 1.0x | 0.9x | 1.1x | 1.1x | 900.1x | 967.5x | 941.1x | - |
| P / S | - | 3.4x | 2.7x | 3.4x | 3.1x | 4.7x | 3511.8x | 3551.3x | 4139.5x | - |
| EV / EBITDA | - | - | - | 42.7x | - | 44.5x | - | - | 60241.9x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | 4.0% | 58.7% | 26.5% | 44.5% | 5.2% | 11.6% | 17.3% | -20.0% | - |
| Revenue CAGR (3y) | - | 18.8% | - | 2.1% | - | - | 1.8% | 6.4% | -15.7% | - |
| Revenue CAGR (5y) | - | 9.6% | - | -4.4% | 2.0% | 3.1% | 2.9% | 3.8% | - | - |
| Gross profit growth (YoY) | - | -23.9% | 32.7% | 30.1% | 38.9% | 12.6% | 8.6% | 22.0% | -23.1% | - |
| Operating income growth (YoY) | - | - | - | 13.6% | -77.7% | 33.7% | 63.0% | 107.8% | -76.8% | - |
| Net income growth (YoY) | - | - | -68.9% | 25.2% | -96.7% | 16.9% | 82.9% | - | -75.7% | - |
| EPS growth (YoY) | - | - | - | 22.2% | - | 28.6% | 78.9% | - | -75.4% | - |
| EPS CAGR (3y) | - | - | - | -27.2% | - | - | -1.0% | 1.1% | -49.2% | - |
| EPS CAGR (5y) | - | - | - | -27.1% | - | - | 19.4% | 13.5% | -9.5% | - |
| FCF growth (YoY) | - | - | - | - | - | 106.1% | - | - | -82.3% | - |
| FCF CAGR (5y) | - | - | - | - | - | 17.2% | - | - | -18.9% | - |
| Book value growth (YoY) | -9.9% | 7.9% | 21.3% | 16.1% | 0.9% | 2.9% | 4.1% | 0.3% | -4.1% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-01-31.
Geographic
$33.90M totalLatin America$16.10M · 47.5%
Asia$13.80M · 40.7%
MX$4.00M · 11.8%
Peer comparison
Same SIC group: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Comparing LAKELAND INDUSTRIES INC against the 5 most active filers in the same SIC group.
Dividends
$0.06/share trailing 12 months · -50.0% YoY
| Ex-date | Per share |
|---|---|
| Nov 17, 2025 | $0.0300 |
| Aug 15, 2025 | $0.0300 |
| May 15, 2025 | $0.0300 |
| Feb 14, 2025 | $0.0300 |
| Nov 15, 2024 | $0.0300 |
| Aug 15, 2024 | $0.0300 |
| May 14, 2024 | $0.0300 |
| Feb 14, 2024 | $0.0300 |
| Nov 14, 2023 | $0.0300 |
| Aug 14, 2023 | $0.0300 |
| May 12, 2023 | $0.0300 |
| Feb 14, 2023 | $0.0300 |